← Open Payments lookup

UJALA FAWAD: Open Payments

NPI 1063662112 · NORWOOD, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,918 in 109 payments from 17 companies in 2025. Trend: 2023 $578 · 2024 $1,680 · 2025 $1,918

Food & beverage: $1,763Education: $155
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.28$376
ABBVIE INC.14$214
Axsome Therapeutics, Inc.8$168
Lundbeck LLC8$162
Otsuka America Pharmaceutical, Inc.7$162
Corium, LLC9$149
Supernus Pharmaceuticals, Inc.8$137
E.R. Squibb & Sons, L.L.C.5$105
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$90
Otsuka Pharmaceutical Development & Commercialization, Inc.4$83

Products named: FANAPT, REXULTI, VRAYLAR, Auvelity, Azstarys, Qelbree, CAPLYTA, COBENFY.

Industry payments across MA — which companies pay providers there.